NuCana PLC (NCNA)
3.965
-0.02
(-0.38%)
USD |
NASDAQ |
May 02, 16:00
4.20
+0.24
(+5.93%)
After-Hours: 20:00
NuCana Total Assets (Quarterly): 35.43M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 35.43M |
| September 30, 2023 | 41.44M |
| June 30, 2023 | 52.04M |
| March 31, 2023 | 60.38M |
| December 31, 2022 | 70.50M |
| September 30, 2022 | 76.67M |
| June 30, 2022 | 80.82M |
| March 31, 2022 | 93.82M |
| December 31, 2021 | 104.56M |
| September 30, 2021 | 120.55M |
| June 30, 2021 | 127.78M |
| March 31, 2021 | 138.65M |
| December 31, 2020 | 146.90M |
| September 30, 2020 | 154.22M |
| Date | Value |
|---|---|
| June 30, 2020 | 78.90M |
| March 31, 2020 | 82.87M |
| December 31, 2019 | 92.13M |
| September 30, 2019 | 93.35M |
| June 30, 2019 | 101.37M |
| March 31, 2019 | 107.25M |
| December 31, 2018 | 110.63M |
| September 30, 2018 | 117.40M |
| June 30, 2018 | 118.81M |
| March 31, 2018 | 126.09M |
| December 31, 2017 | 130.21M |
| June 30, 2017 | 30.76M |
| December 31, 2016 | 33.43M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
35.43M
Minimum
Dec 2023
154.22M
Maximum
Sep 2020
92.23M
Average
92.13M
Median
Dec 2019
Total Assets (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 282.62M |
| Biodexa Pharmaceuticals Plc | 13.43M |
| Autolus Therapeutics PLC | 375.38M |
| Mereo BioPharma Group PLC | 66.50M |
| Bicycle Therapeutics PLC | 595.34M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 16.46M |
| Shareholders Equity (Quarterly) | 18.96M |